CClinicalTrials.gg
RecruitingNCT05933850Updated May 27, 2026

Culturally Adapted Strong Families Programme for Families Living in Gilgit Baltistan, Pakistan

An interventional study of Strong Families Programme Intervention in Mental Health, sponsored by Pakistan Institute of Living and Learning. Recruiting at 1 site in Pakistan. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-27.

Sponsored by Pakistan Institute of Living and Learning · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The aim of this exploratory study is to test the Strong Family (SF) programme in improving family functioning. Participants will be randomized to one of the two study arms 1)- Intervention group in which participants will receive 3 group sessions of SF programme (8-12 families per group) 2)- Control group (control group will be in the waiting list and receive SF training sessions once the study will be completed).

Read the detailed description

This will be multicentre feasibility randomised controlled trial to test the effectiveness of the SF programme in improving family skills outcomes and caregiver and child mental health, as reported by caregivers when implemented in Gilgit-Baltistan. The study will record families' rates of recruitment and attendance to SF programme, evaluate the completeness of programme delivery, cultural acceptability through qualitative interviews and assess the fidelity of training delivery. A small pilot study with N=10 families (a female caregiver (mother) and one child between the age of 8-15 years from each family) will be conducted before main RCT. The study will be conducted in three sites including Karachi, Lahore and Gilgit Baltistan, Pakistan. We will interview a subset of participants i.e. up to 5 caregivers from each study site (N=15 caregivers) to explore participants' opinions on the acceptability of the programme and to explore any barriers or facilitators to participation.

02

Conditions studied

  • Mental Health
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female primary caregiver to a child aged between 8-15 years
  • Able to speak and understand Urdu language
  • Capable to give informed consent

Exclusion criteria

Exclusion Criteria:

  • Families that had already taken part in another family skills training programme in the past 6 months or where the caregiver lived separately from the child
  • Not the primary caregiver of the child
  • Unlikely to be available for the duration of the whole study and outcome assessments (e.g., temporary residence).
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Strong Family Programme Intervention

    There will be 3 weekly group sessions of the strong family programme with caregivers and children (8-12 families per group).

    Behavioral: Strong Families Programme Intervention

  • Active comparator
    Waitlist control group

    This group will be on the waiting list and receive SF programme training sessions once the study will be completed.

    Behavioral: Strong Families Programme Intervention

Interventions

  • BehavioralStrong Families Programme Intervention

    This is a family skills programme providing an evidence-informed prevention to support caregivers to be better parents and strengthen positive age-specific and age-appropriate family functioning and interactions to help prevent drug use, violence and other negative social consequences in their children.

05

What researchers measure

Primary outcomes

  1. Feasibility and acceptability indicators

    We will record feasibility indicators in terms of families' rates of recruitment and attendance to programme, and programme completeness. To evaluate cultural acceptability of programme by families, interviews with caregivers will be conducted to explore family members' opinions on the acceptability of the programme, any barriers or facilitators to participation.

    Time frame: From baseline to end of intervention at 3 weeks (post randomisation)

Secondary outcomes

  1. Strengths and Difficulties Questionnaire

    The Strengths and Difficulties Questionnaire is a brief behavioural screening questionnaire and ask about 25 attributes, some positive and others negative. This will be administered to both child and the caregiver.

    Time frame: At baseline, week 5 and week 9 of post baseline

  2. Parenting and Family Adjustment Scale

    This will measures parenting practices and parental adjustment. This scale has been developed to be used in low resource settings.

    Time frame: At baseline, week 5 and week 9 of post baseline

  3. Child and Youth Resilience Measure

    This is a screening tool to explore the resources available that may bolster resilience.

    Time frame: At baseline, week 5 and week 9 of post baseline

06

Study locations

1 of 1 sites recruiting
  • Community setting
    Karachi, 75600, Pakistan
    Recruiting
07

References and documents

Publications

  • El-Khani A, Asif M, Shahzad S, Bux MS, Maalouf W, Rafiq NUZ, Khoso AB, Chaudhry IB, Van Hout MC, Zadeh Z, Tahir A, Memon R, Chaudhry N, Husain N. Assessing the efficacy of a brief universal family skills programme on child behaviour and family functioning in Gilgit-Baltistan, Pakistan: protocol for a feasibility randomised controlled trial of the Strong Families programme. BMJ Open. 2024 Jul 1;14(6):e081557. doi: 10.1136/bmjopen-2023-081557. PubMed 38951006 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) will be shared with other researchers, encompassing essential information such as demographic details, primary and secondary outcome measures, intervention exposure metrics, and process evaluation data. Rigorous measures will be implemented to ensure the complete de-identification of the data and safeguard the anonymity of individual participants.

Supporting information: Study protocol, Sap, Icf

08

Registry details

Key details

Study ID
NCT05933850
Lead sponsor
Pakistan Institute of Living and Learning
Collaborators
UNODC
Responsible party
Sponsor
First posted
Jul 6, 2023
Start date
Mar 1, 2026
Primary completion
Dec 30, 2026 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
May 27, 2026

Study contacts

MUQADDAS ASIF
Contact
muqaddasasif@pill.org.pk
03364057787
Salman Shahzad
principal investigator · Pakistan Institute of Living and Learning

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion